Human immunodeficiency virus-1 and preconception care

Maternal and Child Health Journal

Volumn 10, Issue 1, 2006, Pages 195-197

  Lampe, Margaret A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV; Perinatal; Preconception care; Pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; HEPATITIS B VACCINE; HYDROXYUREA; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; BREAST FEEDING; CLINICAL TRIAL; DELIVERY; FAMILY PLANNING; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; INFLUENZA; LABOR; LIVER TOXICITY; MATERNAL CARE; MATERNAL NUTRITION; MOTHER CHILD RELATION; PATIENT COUNSELING; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STREPTOCOCCUS INFECTION; TERATOGENICITY; VIRUS TRANSMISSION;

EID: 33748706974     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-006-0131-x     Document Type: Article

References (21)

1. Anderson RN, Smith BL. Deaths: Leading causes for 2001. Nat Vital Stat Rep 2003;52(9):32-3H 53-4. Available at: http://www.cdc.gov/nchs/data/ nvsr/nvsr52/nvsr52_09.pdf. Accessed Feb 3, 2006.
2. Anderson RN, Smith BL. Deaths: Leading causes for 2002. Nat Vital Stat Rep 2005;53(17): 32-H, 53-4. Available at: http://www.cdc.gov/nchs/data/ nvsr/nvsr53/nvsr53_17.pdf. Accessed Feb 3, 2006.
3. Mastro T. Normalizing HIV Testing in Health Care Settings. Oral presentation at the 13th Conference on Retroviruses and Opportunistic Infections; February, 2006; Denver, CO. Abstract 164.
4. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. November 17, 2005. Available at: http://aidsinfo.nih.gov. Accessed February 3, 2006.
5. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
6. CDC. Recommendations of the Public Health Service Task Force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994;43(RR-11):1-20.
7. CDC. U. S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 1995;44 (RR-7):1-15.
8. Cooper ER, Nugent RP, Diaz C, et al. After AIDS Clinical Trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996;174(6):1207-11.
9. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996;275(19):1483-8.
10. Fiscus SA, Adimora AA, Funk ML, et al. Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina. Pediatr Infect Dis J 2002;21(7):664-8.
11. Thomas P, Singh T, Bornschlegel K, et al. Use of ZDV to prevent perinatal HIV in New York City (NYC). 4th Conference on Retroviruses and Opportunistic Infections; January 22-261997; Washington, DC. Abstract 176.
12. Mayaux MJ, Teglas JP, Mandelbrot L, et al. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr 1997;131(6):857-62.
13. Harris NH, Thompson SJ, Ball R, et al. Zidovudine and perinatal human immunodeficiency virus type 1 transmission: A population-based approach. PedHatrics, 2002;109(4):e60. URL: http://www.pediatrics.org/cgi/content/ full/109/4/e60.
14. Guidelines for Perinatal Care. 5th ed. Elk Grove Village, IL and Washington, DC: American Academy of Pediatrics and American College of Obstetricians and Gynecologists; 2002.
15. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004;39:13.
16. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Joint statement of ACOG/AAP on Human immunodeficiency virus screening. 1999. Available at: http://www.acog.org/departments/ dept_notice.cfm?recno= 18&bulletin=961. Accessed Feb 3, 2006.
17. American College of Obstetricians and Gynecologists. Prenatal and perinatal human immunodeficiency virus testing: Expanded recommendations. Committee Opinion No. 304. Obstet Gynecol 2004;104:1119-24.
18. CDC. Revised recommendations for HIV screening of pregnant women. MMWR 2001;50(RR-19):63-85.
19. Institute of Medicine, National Research Council. Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Washington, DC: National Academy Press; 1999.
20. U. S. Preventive Services Task Force. Screening for HIV: Recommendation statement. Ann Intern Med 2005;143:32-7.
21. Chou R, Smits A, Hoyt Huffman L, et al. Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2005;143:38-54.